Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("TALINOLOL")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 109

  • Page / 5

Export

Selection :

  • and

Determination of talinolol in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry : Application to pharmacokinetic studyHE JUAN; TERHAAG, Bernd; YANG, Li-Ying et al.Journal of chromatography. B. 2007, Vol 853, Num 1-2, pp 275-280, issn 1570-0232, 6 p.Article

Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteersHE JUAN; TERHAAG, Bernd; ZANG CONG et al.European journal of clinical pharmacology. 2007, Vol 63, Num 7, pp 663-668, issn 0031-6970, 6 p.Article

Effect of Grapefruit Juice, Naringin, Naringenin, and Bergamottin on the Intestinal Carrier-Mediated Transport of Talinolol in RatsDE CASTRO, Whocely Victor; MERTENS-TALCOTT, Susanne; DERENDORF, Hartmut et al.Journal of agricultural and food chemistry (Print). 2008, Vol 56, Num 12, pp 4840-4845, issn 0021-8561, 6 p.Article

ZUR PHARMAKOLOGIE VON ( +OU- )-1-(4-CYCLOHEXYLUREIDOPHENOXY)-2-HYDROXY-3-TERT.-BUTYLAMINOPROPAN (TALINOLOL, CORDANUM, 02-115). = PHARMACOLOGIE DU ( +OU- )-1-(4-CYCLOHEXYLUREIDO-PHENOXY) 2-HYDROXY 3-TERBUTYL-AMINO PROPANE (TALINOLOL, CORDANUM, 02-115)FEMMER K; BARTSCH R; LEONHARDT U et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 642-651; BIBL. 36 REF.Article

Determination of talinolol in human plasma using automated on-line solid phase extraction combined with atmospheric pressure chemical ionization tandem mass spectrometryBOURGOGNE, Emmanuel; GRIVET, Chantal; HOPFGARTNER, Gérard et al.Journal of chromatography. B. 2005, Vol 820, Num 1, pp 103-110, issn 1570-0232, 8 p.Article

Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters: Results from the TALIP studySOURGENS, H; SCHMIDT, J; DERENDORF, H et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 1, pp 22-29, issn 0946-1965, 8 p.Article

QUANTITATIVE KOLORIMETRISCHE BESTIMMUNG VON 1-(4-CYCLOHEXYLUREIDOPHENOXY)-2-HYDROXY-3-TERT.-BUTYLAMINOPROPAN (TALINOLOL, CORDANUM, 02-115) IN KOERPERFLUESSIGKEITEN. = DOSAGE COLORIMETRIQUE DU 1-(4-CYCLOHEXYLUREIDO-PHENOXY) 2-HYDROXY 3-TERBUTYLAMINO PROPANE (TALINOLOL, CORDANUM, 02-115) DANS LES MILIEUX BIOLOGIQUESNURNBERGER H.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 671-673; BIBL. 2 REF.Article

UNTERSUCHUNGEN ZUR PHARMAKOKINETIK VON 1-(4-CYCLOHEXYLUREIDOPHENOXY)-2-HYDROXY-3-TERT.-BUTYLAMINOPROPAN (TALINOLOL, CORDANUM, 02-115). I. BLUTSPIEGELVERLAEUFE BEIM HUND. = ETUDES SUR LA PHARMACOCINETIQUE DU 1-(4-CYCLOHEXYLUREIDO-PHENOXY) 2-HYDROXY 3-TERBUTYLAMINO PROPANE (TALINOLOL, CORDANUM, 02-115). TAUX SANGUINS CHEZ LE CHIENFEMMER K; KLEMM W; NURNBERGER H et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 673-675; BIBL. 2 REF.Article

Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humansTUBIC, Marija; WAGNER, Daniel; SPAHN-LANGGUTH, Hildegard et al.European journal of pharmaceutical sciences. 2006, Vol 29, Num 3-4, pp 231-239, issn 0928-0987, 9 p.Conference Paper

Grapefruit juice-drug interactions : Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in caco-2 cellsDE CASTRO, Whocely Victor; MERTENS-TALCOTT, Susanne; DERENDORF, Hartmut et al.Journal of pharmaceutical sciences. 2007, Vol 96, Num 10, pp 2808-2817, issn 0022-3549, 10 p.Article

Lack of effect of continuous glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteersMIAO YAN; FANG, Ping-Fei; LI, Huan-De et al.European journal of clinical pharmacology. 2013, Vol 69, Num 3, pp 515-521, issn 0031-6970, 7 p.Article

In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effectTUBIC, Marija; WAGNER, Daniel; SPAHN-LANGGUTH, Hilde et al.Pharmaceutical research. 2006, Vol 23, Num 8, pp 1712-1720, issn 0724-8741, 9 p.Article

Modulation of drug transport by selected flavonoids : Involvement of P-gp and OCT?OFER, Monika; WOLFFRAM, Siegfried; KOGGEL, Annette et al.European journal of pharmaceutical sciences. 2005, Vol 25, Num 2-3, pp 263-271, issn 0928-0987, 9 p.Article

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinololHAENISCH, Sierk; MAY, Karen; WEGNER, Danilo et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 4, pp 357-365, issn 1744-6872, 9 p.Article

Determination of cordanum (talinolol) in biological materials by stripping voltammetryIVANOVSKAYA, E. A; SINEGUBOVA, Yu. V; LUSTA, I. V et al.Journal of analytical chemistry (New York, NY). 1999, Vol 54, Num 11, pp 1063-1064, issn 1061-9348Article

CHRONISCHE TOXIZITAETSPRUEFUNG VON 1-(4-CYCLOHEXYLUREIDOPHENOXY)-2-HYDROXY-3-TERT.-BUTYLAMINOPROPAN (TALINOLOL, CORDANUM, 02-115) AN RATTE UND BEAGLE-HUND. = ETUDE DE TOXICITE CHRONIQUE DE 1-(4-CYCLOHEXYLUREIDO-PHENOXY) 2-HYDROXY 3-TERBUTYLAMINO PROPANE (TALINOLOL, CORDANUM, 02-115) CHEZ LE RAT ET LE CHIEN BEAGLEBARTSCH R; MERBT EM; RIEDEL H et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 659-668; BIBL. 2 REF.Article

KLINISCH-PHARMAKOLOGISCHE UNTERSUCHUNGEN ZUR BRONCHOKONSTRIKTORISCHEN NEBENWIRKUNG DES BETA 1-REZEPTOREN BLOCKERS TALINOLOL (CORDANUM,02-115) BEI ASMATIKERN UND PATIENTEN MIT CHRONISCHEN OBSTRUKTIVEN LUNGENERKRAN KUNGEN. = ETUDES CLINICO-PHARMACOLOGIQUES SUR L'EFFET SECONDAIRE BRONCHOCONSTRICTEUR DU BETA -BLOQUANT TALINOLOL (CORDANUM, 02-115) CHEZ LES ASTHMATIQUES ET LES PATIENTS ATTEINTS DE PNEUMOPATHIES CHRONIQUES OBSTRUCTIVITESKANDT D; HACKENBERGER F.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 681-683; BIBL. 19 REF.Article

WIRKUNG VON 1-(4-CYCLOHEXYLUREIDOPHENOXYL)-2-HYDROXY-3-TERT.-BUTYLAMINOPROPAN (TALINOLOL, CORDANUM, 02-115), PRACTOLOL UND PROPRANOLOL AUF DEN LIPIDGEHALT DES SERUMS DER RATTE. = ACTION DU 1-(4-CYCLOHEXYLUREIDO-PHENOXY) 2-HYDROXY 3-TERBUTYLAMINO PROPANE (TALINOLOL, CORDANUM, 02-115), DU PRACTOLOL ET DU PROPRANOLOL SUR LES LIPIDES SERIQUES DU RATLEONARDT U; NURNBERGER H; FEMMER K et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 656-658; BIBL. 17 REF.Article

In Vivo Probes of Drug Transport: Commonly Used Probe Drugs to Assess Function of Intestinal P-glycoprotein (ABCB1) in HumansOSWALD, Stefan; TERHAAG, Bernd; SIEGMUND, Werner et al.Handbook of experimental pharmacology. 2011, Vol 201, pp 403-447, issn 0171-2004, 45 p.Article

P-glycoprotein and surfactants: Effect on intestinal talinolol absorptionBOGMAN, Katrijn; ZYSSET, Yvonne; DEGEN, Lukas et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 1, pp 24-32, issn 0009-9236, 9 p.Article

Role of the Multidrug Transporter Proteins ABCB1 and ABCC2 in the Diaplacental Transport of Talinolol in the Term Human PlacentaMAY, Karen; MINARIKOVA, Veronika; LINNEMANN, Knud et al.Drug metabolism and disposition. 2008, Vol 36, Num 4, pp 740-744, issn 0090-9556, 5 p.Article

In-vitro-Untersuchungen zur Wechselwirkung von Talinolol mit verschiedenen Erythromycinpräparaten und -reinsubstanzen = In vitro investigations of the interactions of talinolol with different erythromycin preparations and substancesOERTEL, R; SCHWARZ, U; KIRCH, W et al.Pharmazie. 1998, Vol 53, Num 4, pp 277-278, issn 0031-7144Article

HAEMODYNAMISCHE WIRKUNGEN DER NEUEN BETA -REZEPTOREN BLOCKIERENDEN SUBSTANZ TALINOLOL (CORDANUM, 02-115) AM MENSCHEN. = EFFETS HEMODYNAMIQUES DU NOUVEAU BETA -BLOQUANT TALINOLOL (CORDANUM, 02-115) CHEZ L'HOMMEWOLF P; FELLER K; FEMMER K et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 678-681; BIBL. 20 REF.Article

TALINOLOL (CORDANUM, 02-115) IM TERATOLOGISCHEN VERSUCH. = ETUDE TERATOLOGIQUE DU TALINOLOL (CORDANUM, 02-115)WENDLER D; SCHMIDT W.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 669-671Article

UNTERSUCHUNGEN ZUR PHARMAKOKINETIK VON 1-(4-CYCLOHEXYLUREIDOPHENOXY)-2-HYDROXY-3-TERT.-BUTYLAMINOPROPAN (TALINOLOL, CORDANUM, 02-115). II. AUSSCHEIDUNG, BLUTSPIEGEL UND VERTEILUNG DER 14C-MARKIERTEN VERBINDUNG BEI DER RATTE. = ETUDES SUR LA PHARMACOCINETIQUE DU 1-(4-CYCLOHEXYLUREIDO-PHENOXY) 2-HYDROXY 3-TERBUTYLAMINOPROPANE (TALINOLOL, CORDANUM, 02-115). ELIMINATION, TAUX SANGUINS ET REPARTITION DU COMPOSE MARQUE AU 14C CHEZ LE RATKLEMM W; WENZEL A.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 10; PP. 675-677Article

  • Page / 5